Active Ingredient(s):Bempedoic Acid + Ezetimibe FDA Approved: * February 26, 2020 Pharm Company: *ESPERION THERAPS INC Category:Cholesterol
Bempedoic acid/ezetimibe, sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol. It is a combination of bempedoic acid and ezetimibe.
The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation.
Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor and ezetimibe is a ...
* May have multiple approval dates, manufacturers, or labelers.